MedTrace Logo

PPI Sequencing Study

NCT00384592 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2009-03-11

No results posted yet for this study

Summary

The purpose of this study is to assess how patients with gastro-oesophageal reflux disease (heartburn) who are currently receiving treatment with a proton pump inhibitor but are still experiencing symptoms will benefit from a change in treatment.

Conditions

  • Gastro-Oesophageal Reflux Disease

Interventions

DRUG

Esomeprazole

PROCEDURE

Physical exam

PROCEDURE

Pregnancy test if applicable

Sponsors & Collaborators

Principal Investigators

  • Rhiannon Rowsell, MD · AstraZeneca

  • Roger Jones, MD · UCL

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-09-30
Primary Completion
2007-05-31
Completion
2007-05-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00384592 on ClinicalTrials.gov